Eli Lilly And Stock Analysis

Eli Stock Analysis Notes

About 83.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.85. Eli Lilly recorded earning per share (EPS) of 11.74. The entity last dividend was issued on the 14th of February 2025. The firm had 2:1 split on the 16th of October 1997. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 35000 people. To find out more about Eli Lilly and contact Jacob Naarden at 317 276 2000 or learn more at https://www.lilly.com.

Eli Lilly Investment Alerts

Eli Lilly Upcoming and Recent Events

Eli Largest EPS Surprises

View All Earnings Estimates

Eli Lilly Environmental, Social, and Governance (ESG) Scores

Eli Lilly Thematic Classifications

Eli Stock Institutional Investors

Note, although Eli Lilly's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Eli Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 759.27 B.

Eli Profitablity

The company has Net Profit Margin of 0.24 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.42 %, which entails that for every 100 dollars of revenue, it generated $0.42 of operating income.

Management Efficiency

Eli Lilly has Return on Asset of 0.1395 % which means that on every $100 spent on assets, it made $0.1395 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.841 %, implying that it generated $0.841 on every 100 dollars invested. Eli Lilly's management efficiency ratios could be used to measure how well Eli Lilly manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Eli Lilly's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.12 in 2025, whereas Return On Capital Employed is likely to drop 0.25 in 2025. At this time, Eli Lilly's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 6.9 B in 2025, despite the fact that Non Current Assets Total are likely to grow to (3.3 B).

Technical Drivers

As of the 16th of February 2025, Eli Lilly shows the Mean Deviation of 1.48, downside deviation of 2.09, and Coefficient Of Variation of 4168.94. In respect to fundamental indicators, the technical analysis model provides you with a way to check existing technical drivers of Eli Lilly, as well as the relationship between them.

Eli Lilly Price Movement Analysis

Eli Lilly Insider Trading Activities

Eli Lilly Outstanding Bonds

Eli Lilly Predictive Daily Indicators

Eli Lilly Corporate Filings

Eli Lilly Forecast Models

Eli Lilly's time-series forecasting models are one of many Eli Lilly's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eli Lilly's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eli Lilly prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eli shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eli Lilly. By using and applying Eli Stock analysis, traders can create a robust methodology for identifying Eli entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Eli analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Eli analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Eli Lilly and stock analysis indicators help investors evaluate how Eli Lilly stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Eli Lilly shares will generate the highest return on investment. By understating and applying Eli Lilly stock analysis, traders can identify Eli Lilly position entry and exit signals to maximize returns.

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.